Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 14/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19712991 | 0.84 | CHRM3 (0.45) | CHRM3CHRM2CHRM1HTTL3MBTL1 | |
| SCHEMBL23115524 | 0.83 | TSHR (0.49) | L3MBTL1NPSR1MAPTTSHR | |
| SCHEMBL19713012 | 0.82 | CHRM3 (0.54) | CHRM3CHRM2CHRM1 | |
| SCHEMBL19713001 | 0.81 | L3MBTL1 (0.50) | HTTL3MBTL1NPSR1MAPT | |
| SCHEMBL17847442 | 0.80 | CHRM3 (0.47) | CHRM3CHRM2CHRM1HTTL3MBTL1 | |
| SCHEMBL16127811 | 0.79 | L3MBTL1 (0.38) | CHRM3CHRM2CHRM1HTTL3MBTL1 | |
| SCHEMBL18272058 | 0.78 | CHRM3 (0.38) | CHRM3CHRM2CHRM1HTTL3MBTL1 | |
| SCHEMBL17847512 | 0.77 | CHRM3 (0.50) | CHRM3CHRM2CHRM1HTTL3MBTL1 | |
| SCHEMBL19712992 | 0.77 | L3MBTL1 (0.46) | L3MBTL1NPSR1MAPT | |
| SCHEMBL22213477 | 0.77 | CHRM3 (0.35) | CHRM3CHRM2CHRM1HTTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107223121-B | Wet stable holographic media | 科思创德国股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-3233791-B1 | MOISTURE STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2020-08-12 | — | — | EP | disclosed |
| US-10329244-B2 | Moisture-stable holographic media | COVESTRO DEUTSCHLAND AG (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329244-B2 | Moisture-stable holographic media | NEFM, MDM4, BHMT2 | CHRM3 4040/4885CHRM2 3183/4885CHRM1 2559/4885 |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | NEFM, MDM4, BHMT2 | CHRM3 4040/4885CHRM2 3183/4885CHRM1 2559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.